Clinic
Buffalo Clinical Lab Testing Corp.
Buffalo Clinical Lab Testing Corp. was paid $0.00 by Medicaid between Feb 2024 and Sep 2024, across 5 billing codes. Its largest line is 80305, — 0% of everything it billed.
33Billing provider infoBUFFALO CLINICAL LAB TESTING CORP.
LACKAWANNA, NY 14218
LACKAWANNA, NY 14218
33aNPI1639822513assigned 01/31/2022
33bProvider typeHealth Service Clinic/Center
28Total paid$0.00
24GClaims390
24DCodes billed5
24AFirst – last monthFeb 2024 – Sep 2024
Compared with peers
Next to other Health Service Clinic/Center providers in New York
Rank by total paid#54 of 54
Median peer was paid$410K
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2024incomplete | 390 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80305 | 0% | 156 | 96 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 16 | 13 | $0.00 |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 0% | 40 | 39 | $0.00 |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 0% | 16 | 13 | $0.00 |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 0% | 162 | 98 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGOODWIN, FRANCESCA (DIRECTOR)